| Mrs Rebecca Lee Allbright, DPT | |
|
1667 Lucerne St Ste B, Minden, NV 89423-4360 | |
| (775) 783-7606 | |
| (775) 783-7605 |
| Full Name | Mrs Rebecca Lee Allbright |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 1667 Lucerne St Ste B, Minden, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386808772 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 3546 (New Mexico) | Secondary |
| 225100000X | Physical Therapist | 2406 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Rebecca Lee Allbright, DPT Po Box 280, Minden, NV 89423-0280 Ph: (775) 783-7606 | Mrs Rebecca Lee Allbright, DPT 1667 Lucerne St Ste B, Minden, NV 89423-4360 Ph: (775) 783-7606 |
News Archive
Gilead Sciences, Inc. today announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for marketing approval for the fixed-dose combination of Truvada® (emtricitabine and tenofovir disoproxil (as fumarate)) and Tibotec Pharmaceuticals' investigational non-nucleoside reverse transcriptase inhibitor TMC278 (rilpivirine (as hydrochloride)) for the treatment of HIV-1 infection in adults.
A pregnant woman's exposure to tobacco smoke and pollution from road traffic can influence the development of behavioral outcomes in early childhood.
Using a RAND assessment tool, researchers aimed to "predict the effects of self-insurance and grandfathering exemptions on coverage and premiums available" on policies for small businesses sold in the insurance exchanges.
Patients who have had a heart attack and are treated with a high dose of a statin drug did not have significant reduction in the primary outcome of major cardiac events (coronary death, nonfatal acute heart attack, or cardiac arrest with resuscitation), but did appear to have reduced risk when certain secondary outcomes (composite end points of any coronary heart disease event) were examined, according to a study in the November 16 issue of JAMA.
Archivel Farma, S.L. has announced that its breakthrough treatment for tuberculosis (TB) will shortly start phase II clinical trials. The treatment uses the company's unique combination of its novel therapeutic vaccine called RUTI® in conjunction with an antibiotic. This cuts treatment time from nine months to one month, which reduces side effects and healthcare costs, by preventing re-infection during the eradication process. The company expects commercial availability in 2015.
› Verified 9 days ago
Bodywise Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 1667 Lucerne St Ste B, Minden, NV 89423 Phone: 775-783-7606 Fax: 775-783-7605 | |
Erin Mcmullin, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1667 Lucerne St Ste B, Minden, NV 89423 Phone: 775-783-7606 Fax: 775-783-7605 | |
Danielle Joyce Rohrbacher Moorad, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1701 County Rd, Suite B, Minden, NV 89423 Phone: 775-782-4466 Fax: 775-783-9708 | |
Miss Monique B. Haviland, MSPT, CSCS, PES, CPI Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1667 Lucerne St, Suite B, Minden, NV 89423 Phone: 775-783-7606 Fax: 775-783-7605 | |
Gary Russell Standifer, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1667 Lucerne St, Suite B, Minden, NV 89423 Phone: 775-783-7606 Fax: 775-783-7605 | |
Emily Josephine Burns, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1667 Lucerne St Ste B, Minden, NV 89423 Phone: 775-783-7606 Fax: 775-783-7605 | |
William Scott Wall, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1625 West Hwy 88, Suite 302, Minden, NV 89423 Phone: 775-782-4422 Fax: 775-782-4232 |